Mivebresib

• Catalog number
  B1564-5
• Price
  Please ask
• Size
  5 mg

• Alternative_name
  N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide;  ABBV-075
• Description
  Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.
• CAS Number
  1445993-26-9
• Molecular Formula
  C₂₂H₁₉F₂N₃O₄S
• Molecular Weight
  459.47
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO
• Handling
  Protect from air and light
• Tag Line
  A potent BET inhibitor
• Storage Condition
  -20°C
• Shipping Condition
  Gel Pack
• Shelf Life
  36 months
• PubChem CID
  71600087
• PubChem CID Link
• SMILES
  CCS(=O)(=O)NC1=CC(=C(C=C1)OC2=C(C=C(C=C2)F)F)C3=CN(C(=O)C4=C3C=CN4)C
• InChi
  InChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6
• InChi Key
  RDONXGFGWSSFMY-UHFFFAOYSA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  Mivebresib  
• Short name
  Mivebresib
• Alternative name
  Mivebresib

Similar products